CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society Impact of Myocardial Scar on Prognostic Implication of Secondary Mitral Regurgitation in Heart Failure Fluid Volume Overload and Congestion in Heart Failure: Time to Reconsider Pathophysiology and How Volume Is Assessed Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) Study SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL Frequency, predictors, and prognosis of ejection fraction improvement in heart failure: an echocardiogram-based registry study The spectrum of heart failure: value of left ventricular ejection fraction and its moving trajectories Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction
|<<... 2 3 4 5 6 7 8 ...>>|

Clinical TrialNovember 10, 2018

JOURNAL：N Engl J Med. Article Link

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

SD Wiviott，I Raz，DECLARE–TIMI 58 Investigators. Keywords: Diabetes and Cardiometabolic Disease, Dyslipidemia, Heart Failure and Cardiomyopathies, Prevention, Acute Heart Failure, Hypertension, Smoking

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top